Andrew J. Armstrong, MD, MSc | Authors

November 01, 2015

This management guide covers the treatment, diagnosis, and staging of prostate cancer.

April 27, 2012

Two experts discuss newly available and upcoming treatment options, such as abiraterone and MDV3100, for patients with castration-resistant prostate cancer.

January 17, 2012

These are, indeed, exciting times for patients with metastatic prostate cancer and the clinicians who care for them.

July 02, 2010

In 2010, we have the clinical opportunity to choose among several “targeted” agents when treating patients with metastatic renal cell carcinoma (RCC).

June 07, 2010

In this exclusive ASCO podcast, Andrew J. Armstrong, MD, ScM, Assistant Professor of Medicine and Surgery Duke Comprehensive Cancer Center, Departments of Medicine and Surgery, Divisions of Medical Oncology and Urology, addressed the vexing clinical issue of chemotherapy’s limited effectiveness in advanced renal cell carcinoma.